FemHealth Ventures

Fogarty Innovation is a nonprofit organization established in 2007 and based in Mountain View, California, focused on advancing medical innovation to enhance human health. The organization supports promising innovators and researchers in transforming creative ideas into practical solutions for patient care. It provides mentorship and educational resources throughout the innovation process, facilitating access to intellectual, physical, and financial tools necessary to advance medical concepts from initiation to application. Fogarty Innovation operates two main programs: one that fosters innovation for startups and another aimed at educating the next generation of inventors. Through these initiatives, it aims to propel research and development in the medical field.

Raydiant Oximetry, Inc. is a medical device company founded in 2015 and headquartered in Mountain View, California. The company focuses on improving childbirth outcomes for mothers and infants by developing a low-cost, non-invasive device that monitors fetal oxygen levels during labor. This innovative technology aims to provide real-time insights into fetal oxygenation, which can help clinicians make informed decisions and reduce the risks associated with childbirth, such as birth injuries and unnecessary cesarean sections. By enhancing patient care and potentially lowering healthcare costs, Raydiant Oximetry's device addresses critical needs in maternal and fetal health.

BioAesthetics Corporation, founded in 2015 as a spin-out from Tulane University, specializes in developing innovative reconstruction solutions for breast cancer patients who have undergone mastectomies. The company's primary product is a tissue-engineered nipple-areolar complex (NAC), designed to facilitate the regeneration of the nipple and areola during the breast reconstruction phase. This biologically derived graft serves as an acellular, off-the-shelf option for plastic and reconstructive surgeons, allowing the patient's own cells to integrate and restore the NAC. Currently in the pre-clinical phase, this patent-pending technology aims to improve surgical outcomes and enhance the quality of life for patients with incomplete or removed NACs due to disease, surgery, or birth defects. BioAesthetics is headquartered in Research Triangle Park, North Carolina.